Rawa K. Ismail

Leiden, ZH 2333AA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Journal: EClinicalMedicine

Published: September 11, 2023

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.

Journal: Cancers

Published: March 20, 2023

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC.

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC.

Journal: BMC medical research methodology

Published: January 28, 2023

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.

Journal: JCO oncology practice

Published: August 09, 2022

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.

Journal: Melanoma research

Published: June 15, 2022

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC.

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC.

Journal: BMC medical research methodology

Published: March 27, 2022

Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?

Journal: Breast (Edinburgh, Scotland)

Published: February 22, 2022

Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.

Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 15, 2021

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer.

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: November 01, 2021

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Journal: Journal of medical Internet research

Published: September 29, 2021

The unfavorable effects of COVID-19 on Dutch advanced melanoma care.

The unfavorable effects of COVID-19 on Dutch advanced melanoma care.

Journal: International journal of cancer

Published: June 24, 2021

An invisible group of COVID-19 victims; impact on Dutch lung cancer care.

An invisible group of COVID-19 victims; impact on Dutch lung cancer care.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 17, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026